PT1295890E - Novos derivados de pirazina ou os seus sais, composicoes farmaceuticas que os contem, e compostos intermedios utilizados na sua producao - Google Patents

Novos derivados de pirazina ou os seus sais, composicoes farmaceuticas que os contem, e compostos intermedios utilizados na sua producao

Info

Publication number
PT1295890E
PT1295890E PT02028152T PT02028152T PT1295890E PT 1295890 E PT1295890 E PT 1295890E PT 02028152 T PT02028152 T PT 02028152T PT 02028152 T PT02028152 T PT 02028152T PT 1295890 E PT1295890 E PT 1295890E
Authority
PT
Portugal
Prior art keywords
salts
production
contain
pyrazine derivatives
compounds
Prior art date
Application number
PT02028152T
Other languages
English (en)
Inventor
Egawa Hiroyuki
Furuta Yousuke
Jun Sugita
Uehara Sayuri
Hamamoto Shoichi
Yonezawa Kenji
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of PT1295890E publication Critical patent/PT1295890E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
PT02028152T 2000-02-16 2001-02-14 Novos derivados de pirazina ou os seus sais, composicoes farmaceuticas que os contem, e compostos intermedios utilizados na sua producao PT1295890E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000037486 2000-02-16
JP2000040439 2000-02-18
JP2000090071 2000-03-29

Publications (1)

Publication Number Publication Date
PT1295890E true PT1295890E (pt) 2005-06-30

Family

ID=27342371

Family Applications (2)

Application Number Title Priority Date Filing Date
PT02028152T PT1295890E (pt) 2000-02-16 2001-02-14 Novos derivados de pirazina ou os seus sais, composicoes farmaceuticas que os contem, e compostos intermedios utilizados na sua producao
PT01904434T PT1256588E (pt) 2000-02-16 2001-02-14 Derivados de pirazina originais ou os seus sais, preparacoes farmaceuticas, contendo os derivados ou os seus sais e produtos intermedios para a preparacao de ambos

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT01904434T PT1256588E (pt) 2000-02-16 2001-02-14 Derivados de pirazina originais ou os seus sais, preparacoes farmaceuticas, contendo os derivados ou os seus sais e produtos intermedios para a preparacao de ambos

Country Status (15)

Country Link
US (1) US6800629B2 (pt)
EP (2) EP1256588B1 (pt)
JP (2) JP4379767B2 (pt)
KR (3) KR100589935B1 (pt)
CN (1) CN1239511C (pt)
AT (2) ATE288443T1 (pt)
AU (1) AU2001232287A1 (pt)
BR (2) BRPI0108374B8 (pt)
CA (1) CA2398620C (pt)
DE (2) DE60108724T2 (pt)
DK (1) DK1295890T3 (pt)
ES (2) ES2237550T3 (pt)
MX (1) MXPA02007890A (pt)
PT (2) PT1295890E (pt)
WO (1) WO2001060834A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04001361A (es) * 2001-08-14 2004-05-27 Toyama Chemical Co Ltd Metodo novedoso para inhibir el crecimiento de virus y/o metodo virucida, y un analogo novedoso de un nucleotido de pirazina o de un nucleosido de pirazina.
AU2005289517A1 (en) * 2004-09-24 2006-04-06 Centre National De La Recherche Scientifique Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus
EP2545923A1 (en) * 2005-12-22 2013-01-16 Alchemia Limited Antibacterial agents
ES2373469T3 (es) * 2006-05-31 2012-02-03 Toyama Chemical Co., Ltd. Agente contra el virus de la glosopeda para un animal que pertenece a la familia suidae o de los ovinos, y método para la prevención o tratamiento de glosopeda en un animal que pertenece a la familia suidae o de los ovinos.
ES2470740T3 (es) * 2007-09-27 2014-06-24 Toyama Chemical Co., Ltd. Sal de amina orgánica de 6-fluoro-3-hidroxi-2-pirazinocarbonitrilo y método para su producción
JP5364327B2 (ja) * 2008-09-26 2013-12-11 富士フイルム株式会社 ハロピラジンカルボキサミド化合物の製造方法
US8586741B2 (en) 2009-01-28 2013-11-19 Nippon Soda Co., Ltd. Method for producing dichloropyrazine derivative
JP5559604B2 (ja) * 2009-05-27 2014-07-23 富山化学工業株式会社 ３，６−ジクロロ−２−ピラジンカルボニトリルの製造法
HUE026794T2 (en) 2010-09-30 2016-07-28 Toyama Chemical Co Ltd The oleum salt of 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
DK2623498T3 (en) 2010-09-30 2016-02-22 Toyama Chemical Co Ltd Sodium salt of 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
SG190772A1 (en) * 2010-11-12 2013-08-30 Fujifilm Corp Pyrazino[2,3-d]isooxazole derivative
CN102846617B (zh) * 2011-07-01 2016-01-13 中国人民解放军军事医学科学院毒物药物研究所 3－(丁基氧基)－2－吡嗪甲酰氨的制备方法和用途
WO2013004141A1 (zh) * 2011-07-01 2013-01-10 中国人民解放军军事医学科学院毒物药物研究所 3－烷氧基取代－2－吡嗪甲酰氨类化合物及其用途
CN105732748B (zh) * 2014-12-12 2019-01-01 浙江医药股份有限公司新昌制药厂 一种核苷酸类似物及其制备方法、以及含有核苷酸类似物的药物组合物及其应用
WO2016172205A1 (en) * 2015-04-20 2016-10-27 Emory University Managing ebola viral infections
ES2865296T3 (es) * 2015-06-09 2021-10-15 Fujifilm Toyama Chemical Co Ltd Cristal de 6-bromo-3-hidroxi-2-pirazincarboxamida y método para su producción
CN104961691A (zh) * 2015-07-11 2015-10-07 长沙深橙生物科技有限公司 3-(2-氟苯氧基)吡嗪-2-羧酸的制备方法
CN105037281A (zh) * 2015-07-11 2015-11-11 长沙深橙生物科技有限公司 3-(3-氟苯氧基)吡嗪-2-羧酸的制备方法
CN105017166A (zh) * 2015-07-11 2015-11-04 长沙深橙生物科技有限公司 3-(3-溴苯氧基)吡嗪-2-羧酸的制备方法
CN104961690A (zh) * 2015-07-11 2015-10-07 长沙深橙生物科技有限公司 3-(4-氟苯氧基)吡嗪-2-羧酸的制备方法
CN107641106A (zh) * 2016-07-22 2018-01-30 大连鸿凯化工科技发展有限公司 法匹拉韦中间体以及法匹拉韦的合成方法
CN110678473A (zh) * 2017-04-25 2020-01-10 大原药品工业株式会社 核苷类抗癌药或抗病毒药的5’位二苄基单磷酸酯衍生物
CN111265528A (zh) * 2020-01-21 2020-06-12 中国人民解放军军事科学院军事医学研究院 法匹拉韦在治疗冠状病毒感染方面的应用
CN113248450B (zh) * 2020-02-07 2024-04-12 北京四环制药有限公司 一种法匹拉韦的制备方法
CN113735784A (zh) * 2020-05-28 2021-12-03 南京桦冠生物技术有限公司 6-氟-3-羟基吡嗪-2-甲酰胺的制备方法
WO2021255681A1 (en) * 2020-06-17 2021-12-23 Hikal Limited A simple process for the preparation of favipiravir and its intermediates thereof
CN111704582B (zh) * 2020-06-23 2021-06-11 杭州煌森生物科技有限公司 一种法匹拉韦及其衍生物的制备方法
KR20230034848A (ko) * 2020-07-06 2023-03-10 옵티머스 드럭스 (피) 엘티디 파비피라비르의 합성
CN114656412A (zh) * 2020-12-22 2022-06-24 山东特珐曼药业有限公司 一种法匹拉韦的合成方法
CN112552245B (zh) * 2020-12-29 2022-08-02 苏州正济药业有限公司 法匹拉韦的合成方法
CN112851589B (zh) * 2021-01-25 2022-10-11 山东邹平大展新材料有限公司 一种法匹拉韦中间体6-溴-3-羟基吡嗪-2-甲酰胺的制备方法
WO2023118896A1 (en) 2021-12-23 2023-06-29 Subintro Limited Novel antiviral compositions comprising oleic acid
CN114478404A (zh) * 2022-03-17 2022-05-13 浙江海正药业股份有限公司 一种法维拉韦中间体羟基物的纯化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0394464A4 (en) * 1988-08-22 1991-04-03 Idemitsu Kosan Company Limited Oxirane derivatives and herbicides containing same as active ingredients
DE59209008D1 (de) * 1991-08-17 1997-12-11 Hoechst Ag 2-Fluorpyrazine, Verfahren zu ihrer Herstellung und ihre Verwendung in flüssigkristallinen Mischungen
KR100585240B1 (ko) * 1998-08-20 2006-06-01 토야마 케미칼 컴퍼니 리미티드 질소함유 복소환 카르복사미드 유도체 또는 그 염 및 이를함유하는 항바이러스제

Also Published As

Publication number Publication date
CN1418220A (zh) 2003-05-14
KR20030032918A (ko) 2003-04-26
DE60110415T2 (de) 2005-09-29
ATE288443T1 (de) 2005-02-15
US20030130213A1 (en) 2003-07-10
ES2240645T3 (es) 2005-10-16
ES2237550T3 (es) 2005-08-01
BRPI0116967B8 (pt) 2021-05-25
KR100604955B1 (ko) 2006-07-26
US6800629B2 (en) 2004-10-05
BRPI0108374B8 (pt) 2021-05-25
DE60108724T2 (de) 2005-06-23
JP2009161553A (ja) 2009-07-23
JP5038345B2 (ja) 2012-10-03
ATE294185T1 (de) 2005-05-15
BRPI0108374B1 (pt) 2017-10-10
KR100589935B1 (ko) 2006-06-15
EP1295890B1 (en) 2005-04-27
BRPI0116967B1 (pt) 2018-05-22
EP1295890A1 (en) 2003-03-26
MXPA02007890A (es) 2002-10-31
BR0108374A (pt) 2003-03-18
DE60108724D1 (de) 2005-03-10
AU2001232287A1 (en) 2001-08-27
CA2398620C (en) 2009-06-23
PT1256588E (pt) 2005-05-31
CN1239511C (zh) 2006-02-01
EP1256588A1 (en) 2002-11-13
CA2398620A1 (en) 2001-08-23
WO2001060834A1 (fr) 2001-08-23
DE60110415D1 (de) 2005-06-02
EP1256588A4 (en) 2003-03-26
DK1295890T3 (da) 2005-05-17
KR20030048108A (ko) 2003-06-18
KR20030034120A (ko) 2003-05-01
BRPI0116967A2 (pt) 2009-07-14
JP4379767B2 (ja) 2009-12-09
EP1256588B1 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
PT1295890E (pt) Novos derivados de pirazina ou os seus sais, composicoes farmaceuticas que os contem, e compostos intermedios utilizados na sua producao
BR0112986A (pt) Compostos azabicìclicos, o respectivo preparo e a respectiva utilização como medicamentos, notadamente como antibacteriano
BR0313732A (pt) Compostos de pirimido tendo atividade antiproliferativa
BR0116322A (pt) Derivados de difenilazetidinona, processo para sua preparação, medicamentos contendo esses compostos e seu emprego
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
LU90014I2 (fr) Invirase ou un de ses dérivés ou sels pharmaceutiquement acceptables Saquinavir
BR0017050A (pt) Oxazolidinonas suebstituìdas e seu emprego na área da coagulação do sangue
BRPI0417458A (pt) compostos inibidores de dpp-iv, sais faramaceuticamente aceitáveis e pró-fármacos do mesmo, seus processos de preparação, composição farmacêutica compreendendo os mesmos e uso dos referidos compostos na fabricação de medicamento
PT863875E (pt) Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
DK0462812T3 (da) Pyranderivater som inhibitorer af 5-lipoxygenase
BRPI0509368A (pt) antagonistas cgrp selecionados, processo para a sua fabricação bem como seu uso como medicamento
BR0015254A (pt) Derivados de carbamoiloxialquil-azólio substituìdos em n
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
BR0215016A (pt) Piridoquinoxalinas antivirìcas
BR0011700A (pt) Dinitrilas de ácido arilmalÈnico substituìdo como intermediários para a preparação de herbicidas
BR0215067A (pt) Piridoquinoxalinas antivirais
BR0213990A (pt) Derivados de piperazina tendo atividade antagonìstica de sst1
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
BR9805437A (pt) Derivados de benzocicloalquenos heterocìclicos, processo para fabricação de derivados de benzocicloalquenos heterocìclicos e uso de derivados de benzocicloalquenos heterocìclicos.
HRP20050815A2 (en) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
BR0214973A (pt) Derivados de benzotiazina e benzotiadiazina, seu processo de preparação e as composições farmacêuticas que os contêm
BR0113752A (pt) Derivados piperidina para uso inibidores 2,3-óxido esqualeno lanoesterol ciclase
ATE140922T1 (de) 3- oder 4-glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches mittel
PT1476434E (pt) Derivados de piridazina, sua utilizacao como medicamentos e seu processo de preparacao
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin